JACKSONVILLE, FLA. (CN) – A widow says her husband died of internal bleeding while participating in a clinical trial of a new anti-coagulant drug made by Boehringer Ingelheim Pharmaceutical. Oliver Hone, 72, died of gastrointestinal hemorrhaging three weeks into the trial of Dabigatran Etexilate, his widow says in Federal Court.
Linda Hone says Boehringer “either conducted or is still conducting” the clinical trial, throughout the world and in all 50 states. She says the company has failed to warn participants that should an “adverse bleeding event” like Hone’s occur, there is no known anecdote.
She demands damages for wrongful death. She is represented by Earl Hooten and Michael Seelie.